Introduction
Vascularization of cancers was long thought to be provided by neoangiogenesis and active ingrowth of new vessels into the tumor tissue. 3 However, it became clear that vascularization of various cancer types could be funda- Key words: angiogenesis, immunohistochemistry, lymphocytes, macrophages, microvessel density mentally different since beside neoangiogenesis there are several alternative mechanisms that are able to provide appropriate blood supply. These alternative mechanisms are: cooption of preexisting normal vessels, postnatal angiogenesis, glomeruloid angiogenesis and vasculogenic mimicry, all regulated by pro-and anti-angiogenic factors. 17 Vascularization of malignant melanoma is relatively unique since it is provided by cooption of preexisting normal and newly formed peritumoral vessels. During the incorporation phase (tumor tissue expansion), only a small proportion of these microvessels survive in the intratumoral microenvironment. 18 The literature is highly controversial concerning the association of microvessel density (MVD) and clinicopathological parameters of malignant melanoma. Several investigators have suggested a relationship between the extent of tumor vascularity and poor prognosis. 15, 29, 43, 59 However, others found that tumor vascularity was not of prognostic value in this tumor type, or even came to the conclusion that high vascularization was associated with a better prognosis. 8, 25 Melanoma is considered one of the most immunogenic tumors, and is a preferential target of experimental immunotherapeutic protocols. The existence of melanomaassociated antigens and the detection of T lymphocytes recognizing these antigens, both systemically and at the tumor sites, provide evidence that antitumor immune reactions can develop in melanoma patients. However, as tumor progression is often seen in the presence of a substantial lymphocytic infiltration, this immune response is apparently incapable of controlling tumor growth, probably due to multiple mechanisms resulting in tumor escape. 44, 64 As the presence of immune cells in a tumor does not guarantee the development of an efficient immune reaction, the degree of their infiltration does not necessarily correlate with the intensity of antitumor immune response. Further complicated by the different sensitivity of individual tumors to immune effector mechanisms, this could influence the role of mononuclear cell infiltration in the progression of tumors. Moreover, the prognostic importance of the different infiltrating cell types is frequently controversial, which may partly be due to their multiple functions, as discussed below.
Since the majority of tumor-infiltrating cells derive from the circulation, one might expect an association between the density of microvessels and that of infiltrating cells in a tumor. Another reason for such an association could be that tumor-infiltrating host cells are rich sources of angiogenic factors.
Macrophages are one of the predominant types of cells infiltrating human melanomas. They can play a role in the destruction of tumors via their antigen presenting activity as well as via direct tumor cell killing by the production of toxic factors as tumor necrosis factor-alpha (TNF-α), NO or H 2 O 2 . 42, 45 On the other hand, macrophage-derived factors may suppress the immune reactions and stimulate tumor cell proliferation and invasiveness. 32, 42 These cells are also one of the key producers of angiogenic factors including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), transforming growth factor-alpha (TGF-α), platelet-derived endothelial cell growth factor/thymidine phosphorylase (PDECGF/TP) and interleukin-8 (IL-8). 31, 40, 60 Macrophages are also able to transform the extracellular matrix either by the direct secretion of degradative enzymes or by extracellular matrix-modulating cytokines. 48 Torisu et al suggested the possible involvement of TNF-α and IL-1α secreted by macrophages in the neovascularization of melanoma. 61 Infiltration by macrophages has been shown to correlate with vascularization in several tumor types, 24, 37, 41, 49 however, other studies found no such association. 14, 33, 62 Unlike in other tumor types, 24, 33, 37, 41 a prognostic role of macrophage infiltration was not confirmed in cutaneous melanoma. 50 Beside macrophages, T lymphocytes are often major components of tumor infiltrates in many solid tumors, and their central role in antitumor immunity is well established. However, tumor-infiltrating T cells have been shown to be functionally defective, incompletely activated or anergic. 47, 63 Therefore, for the characterization of immune competent cells in tumor infiltrates, it is important to determine their functional and activation state. In malignant melanoma, published results on the pathophysiological role of lymphoid infiltrate (mostly T lymphocytes) are controversial: while some studies found prominent lymphocytic infiltrate a sign of good prognosis, 9, 10 others showed no significant correlation. 5 In our study evaluating T cells expressing the activation markers CD25 and OX40, high peritumoral density of activated T lymphocytes proved a predictor of favorable disease outcome. 35 Beside their immunological role, T cells may also be involved in vascularization processes of tumors. Qin et al has demonstrated that IFN-γ-mediated angiostasis was the primary mechanism of CD8 + effector T cells in mediating tumor rejection in mouse models. 53 On the other hand, production of VEGF by tumor-infiltrating T cells has been described, which could play a role in tumor angiogenesis. 21 Dendritic cells (DCs), as the most potent antigen presenting cells, play key roles in antitumor immune responses. DCs efficiently capture and process tumor antigens, migrate and then reach local lymph nodes, where they activate antigen-specific T lymphocytes. The presence of dendritic cells in tumors has been associated with better prognosis in patients with various cancers. [26] [27] [28] 55 In our study on human cutaneous melanoma patients, high peritumoral density of mature DCs expressing the DC-LAMP marker was associated with significantly better prognosis. 34 On the other hand, several studies have indicated that VEGF inhibits the maturation and function of dendritic cells, and its expression negatively correlated with DC density in tumors. 22, 26, 55 VEGF is thus suggested to be associated not only with the enhancement of angiogenesis, but also with a decline of local immune response in tumors. Recently, it has been shown in ovarian carcinoma that tumor-associated plasmacytoid DCs are able to induce angiogenesis in vivo by producing TNF-α and IL-8, while myeloid DCs caused suppression through IL-12 secretion. 13 Furthermore, DC precursors were demonstrated to express both endothelial and dendritic cell markers, and to be capable of assembling into blood vessels. 12 In the present study we analyzed the relationship among MVD and tumor-infiltrating cells by immunohistochemistry in primary human cutaneous malignant melanoma. We also investigated the possible associations of tumor thickness, ulceration, localization, clinical outcome and patients' sex with the density of the major infiltrating cell types that were shown to be correlated with vascularization.
Materials and methods

Patients
Archival tissue samples were obtained from 52 patients with primary cutaneous malignant melanoma, who underwent surgery between 1980 and 2000 at the Institute of Dermato-Venerology and -Oncology, Semmelweis University, and at the National Institute of Oncology, Budapest. The study was approved by the ethics committees of both institutions. None of the patients received any anticancer treatment prior to surgery. Clinical and pathological characteristics are summarized in Table 1 . The depth of invasion according to Clark ranged from level II to level V, and Breslow index ranged from 1.1 to 9.9 mm. The tumors were grouped into three thickness categories based on the current AJCC (American Joint Committee on Cancer) staging system 4 (1.01-2.0 mm, 2.01-4.0 mm, >4.0 mm), and into three categories according to disease progression during the 5-year follow-up period (nonmetastatic, lymph node metastatic, visceral metastatic). Nineteen patients had not developed metastases during the follow-up period, while eight patients had regional lymph node metastases only, which were excised. Twenty-five patients had developed distant visceral metastases. The 5-year survival of patients in both the nonmetastatic and the lymph node metastatic groups was 100%, while only one patient developing distant visceral metastases survived for more than 5 years (62 months); no patients died of melanoma-unrelated causes during the 5-year follow-up period. Tumors with clinical regression and/or histological signs of late regression were not included in the study.
Immunohistochemical detection of infiltrating cells and microvessels in melanoma samples
Sections of 3 µm cut from formalin-fixed, paraffinembedded cutaneous melanoma samples were used in the study. Immunohistochemistry was performed on deparaffinized serial sections after microwave antigen retrieval. Endogenous peroxidase activity was blocked with incubation of the slides in 3% H 2 O 2 in methanol, and non-specific binding sites were blocked with 3% bovine serum albumin. Polyclonal anti-CD3 (diluted 1:100), monoclonal anti-CD8 (diluted 1:100), anti-CD20 (diluted 1:100), anti-CD34 (diluted 1:50) and anti-CD68 (diluted 1:100) (all from Dako, Glostrup, Denmark) and monoclonal anti-CD1a (Immunotech, Marseilles, France) were used as primary antibodies, and mouse IgG1 (Sigma, St. Louis, MO) for negative control. Biotinylated anti-mouse/antirabbit Ig was used as secondary reagent, followed by streptavidin-peroxidase treatment (LSAB2 System, HRP; Dako). Antibody binding was visualized with 3-amino-9-ethylcarbazole (AEC; Vector Laboratories, Inc., Burlingame, CA), then the slides were counterstained with hematoxylin. 
Evaluation of the immune reactions
Slides were examined using a graticule of 10x10 squares, calibrated as 0.25 mm 2 at 200x magnification. Counting was performed by two investigators (J.K., A.L.), both blinded to the clinical information. Blood vessels were highlighted by staining endothelial cells with anti-CD34 antibody. Any red-staining endothelial cell cluster that was clearly separate from adjacent microvessels, tumor cells, and other connective tissue elements was considered a single, countable microvessel (Fig. 1a,b) . Vessel lumens were not necessary for a structure to be defined as 24 KISS et al PATHOLOGY ONCOLOGY RESEARCH + dendritic cells and CD68 + macrophages was registered separately in intratumoral (infiltrating melanoma cell nests) and peritumoral areas (distributed in the infiltrate along the margin and the base of melanomas) at five randomly selected sites, and the density of positive cells/mm 2 was calculated ( Fig. 1c-f ).
Figure 1. Immunohistochemistry of microvessels and infiltrating cells in cutaneous melanoma. Visualization of peritumoral (a) and intratumoral (b) microvessels using CD34 marker (red signal). (c) Identification of T lymphocytes in peritumoral infiltrate by CD3 marker (red). Note that the majority of the peritumoral infiltrate is composed of T cells. (d) Identification of B cells in the peritumoral infiltrate of melanoma using CD20 marker (red). (e) Identification of macrophages in peritumoral infiltrate of melanoma using CD68 marker (cytoplasmic red signal). (f) Identification of dendritic cells in the peritumoral infiltrate using CD1a marker (red signal
Statistical analysis
Statistical comparison between cell densities in different tumor groups was made by using the Mann-Whitney U test and Kruskal-Wallis test. The correlation between the density of CD3 + , CD8 + , CD20 + , CD68 + , CD1a + infiltrating cells and MVD was evaluated by using Spearman's rank correlation test. All statistics were calculated using the BMDP Statistical Software Pack.
Results
Correlation between microvessel density and tumor infiltrates
We have analyzed the correlations of infiltrating cell densities with MVD in samples grouped according to tumor thickness and metastasis formation. Intratumoral infiltration did not show significant association with MVD in any of these groups for any of the cell types studied. In the case of peritumoral cell densities, when analyzing the whole patient population, the only statistically significant correlation was found between MVD and the density of CD3 + T cells (p<0.05) ( Table 2 ). This association was stronger in the highest thickness category (>4.0 mm), as well as in the group of visceral metastatic tumors (p<0.001 and p<0.01, respectively). In these subgroups of patients similar phenomenon was observed in the case of CD8 + cells ( Table 2 ).
In melanomas thicker than 4.0 mm MVD positively correlated with macrophage density as well, while weak associations were found in the case of B-cell and DC infiltration in visceral metastatic tumors. In contrast, no correlations could be seen for thinner (1.01-2.0 mm) or nonmetastatic melanomas in the case of the majority of markers ( Table 2) .
Analysis of the correlations found in the visceral metastatic group after subdivision of the cases according to tumor thickness indicated that all these associations were present only in the subgroup of melanomas >4.0 mm (n=9), while no significant correlations were seen in the case of tumors ≤4.0 mm (n=16).
Comparison of microvessel densities in the different tumor categories
Peritumoral microvessel density was found to be more than twice as high as intratumoral one (Table 3) , confirming our earlier findings. 18 Peritumoral MVD demonstrated a tendency to increase parallel with tumor thickness, while intratumoral MVD in 2.01-4.0 mm melanomas showed a trend to exceed that of the other two thickness categories, however, these differences were not statistically significant. We could not detect significant differences in MVD when comparing melanomas according to localization, histological type (SSM vs. NM), metastasis formation, or the presence of ulceration in the primary tumors. However, in the male patient group intratumoral MVD was significantly higher than in females (p=0.0303) ( Table 3) .
Variation of T-cell and macrophage infiltration with clinical parameters
In the followings we examined the possible associations of patient and tumor parameters with the density of T cells and macrophages, the two predominating cell types in melanoma infiltrate which showed correlations with vascularization. Intratumoral and peritumoral density of CD68 + macrophages was higher in melanomas thicker than 2.0 mm, compared to thinner ones (p=0.0259 and p=0.0520, respectively) ( Table 4 ). There was no significant difference in macrophage infiltration between the subgroups of 2-4 mm and >4 mm thickness categories. Similarly to MVD, the density of intratumoral macrophage infiltration was lower in females than in males (p=0.0527), while no difference was observed in peritumoral cell density. Localization, histological type, ulceration and clinical outcome did not significantly influence macrophage infiltration. Distant organ metastasis showed a trend for association with lower intratumoral and peritumoral density of CD3 + T lymphocytes, compared to the non-metastatic group (borderline significance) ( Table 5 ). Similar association was observed in the case of peritumoral CD8 + T cells (not shown). Intratumoral and peritumoral T-cell infiltration was not affected by tumor thickness, localization, histological type, and patients' sex, while ulcerated tumors showed a trend to be associated by lower intratumoral density of CD3 + T lymphocytes and lower peritumoral density of CD8 + T cells (Table 5 and not shown).
Discussion
According to our present observations, intra-and peritumoral MVD did not significantly change with tumor thickness and metastatic pattern. Localization, ulceration and histological type (SSM vs. NM) of melanomas did not influence tumor vascularity either. These observations are partly in harmony with our previous data suggesting that peritumoral microvessel density judged by the common hot spot technique is not related to clinicopathological parameters in melanoma. 18 On the other hand, our previous study reported a significant association between the central intratumoral vessel density and visceral metastasis of melanoma. 18 In the present study we did not discriminate central microvessels since we have applied the hot spot technique to analyze the areas of highest vessel density, where we primarily expected an association of MVD with infiltrating cells. The relationship between angiogenesis and macrophage infiltration in cutaneous melanoma is not clear yet. Some authors described a correlation between macrophage number and microvessel count, 48, 61 which was, however, not confirmed by other studies. 62 We could not find significant association between the intratumoral and peritumoral density of macrophages and CD34 + microvessels, the correlation being significant only when we examined peritumoral microvessels in the highest thickness category. Concomitantly, intratumoral and peritumoral macrophage densities were significantly higher in melanomas thicker than 2 mm, compared to thinner ones. Similarly, more intense macrophage infiltration in thicker melanomas has been reported by other observers. 7, 62 Our results support the role of macrophages in vascularization of high-risk melanomas. According to Leek et al, monocytes are continually recruited into tumors, differentiate into tumorassociated macrophages, accumulate in hypoxic areas, and may induce angiogenesis through secretion of angiogenic cytokines including TNF-α, IL-1α and VEGF. 36, 37 In the case of melanoma their role is more complex, since they may increase angiogenesis peritumorally, and, on the other hand, promote the survival of the incorporated vessels intratumorally.
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T lymphocyte infiltration is generally regarded as evidence of an ongoing immune response against the developing neoplasm, however, a possible role of T cells in tumor vascularization has also been suggested. 21 We found that peritumoral microvessel densities correlated significantly with the number of peritumoral CD3 + cells. The correlation was more pronounced in melanomas thicker than 4.0 mm, and also in those with distant metastases, in the latter case probably mainly as a consequence of the higher prevalence of thick tumors in the visceral metastatic group. The association of MVD with T-cell density suggests that, although peritumoral vascular density did not have a significant role in directly modulating melanoma progression, it could influence the intensity of peritumoral T-cell infiltration, therefore, a higher MVD might even have a positive role in contributing to an increased local T-cell density. Alternatively, associations between the intensity of vascularization and T lymphocyte infiltration may be a result of increased concentration of angiogenic factors in T-cellrich peritumoral areas. We observed higher intratumoral microvessel density in males than in females, which was probably not due to differences in other tumor characteristics like thickness or localization, since they did not influence vascularization significantly, and there was no significant difference in the gender distribution according to these parameters. This finding indicates the possible involvement of sex hormones in the vascularization of melanoma. Steroid hormones have been described to have an effect on angiogenesis. Endothelial cells express the classic estrogen receptor, 30 and estradiol was demonstrated to inhibit apoptosis and induce proliferation and migration of these cells. 38, 58 Moreover, estrogen has also been shown to enhance angiogenesis via platelet factor-mediated activation of NF-κB, leading to the production of IL-8, bFGF and VEGF. 57 On the other hand, the endogenous estrogen metabolite, 2-methoxyestradiol has been reported to inhibit endothelial cell proliferation, as well as angiogenesis, tumor growth and metastasis in several tumor types, including melanoma. 16, 20, 52 Medroxyprogesterone also inhibited growth and vascularization of melanoma in the rabbit cornea. 23 Androgens may stimulate angiogenesis through regulation of VEGF levels via the activation of HIF, 39 or through suppressing the secretion of thrombospondin-1, an angiogenesis inhibitor.
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Similarly to MVD, intratumoral macrophage density was also higher in male patients compared to females in our study. This finding might be explained in part by gender-specific differences in the recruitment of macrophages in the tumor. This hypothesis is supported by the demonstration of the inhibitory effect of estrogen on the expression of monocyte chemotactic protein-1 (MCP-1) and on macrophage infiltration in various tissues. 1, 56 According to our results, associations between MVD and infiltrating cell densities were observed only peritumorally, and not intratumorally. This difference might partly be explained by the altered endothelial phenotype in these locations. Loss of several endothelial cell adhesion molecules from tumor-associated microvessels has been described. 46 We have previously reported that intratumoral 28 19 a molecule that is critical in lymphocyte-endothelial cell interactions in the skin. 2 It is tempting to speculate that such changes in intratumoral microvessels can contribute to the defect of immune reaction to melanoma. Supporting this suggestion, in our previous study the loss of VAP-1 expression was associated with poor prognosis of the disease. 19 As an alternative explanation, the absence of correlation between intratumoral cell densities and MVD could derive from differences in the mechanisms of vascular development between intratumoral and peritumoral areas in melanoma. According to our previous findings, 18 endothelial cell proliferation within the tumor participates in vessel dilatation instead of formation of new vessels, the latter being confined mainly to peritumoral areas. As a possible consequence, angiogenic compounds potentially produced by infiltrating cells would only affect peritumoral vascular development in this tumor type.
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Our observations that peritumoral microvessel density was found to be positively correlated with the density of various immune cells (T and B lymphocytes, macrophages and dendritic cells) in thick and in visceral metastatic tumors suggest that a functioning "immune-vascular" network may be associated with tumor progression. This is further supported by our observation that in the case of thin tumors (1-2 mm), the prognosis of which being far better as compared to thick ones, no correlation was detected between MVD and most infiltrating cell types. These findings might also help us to better interpret the higher vascularization of regressive melanomas, 6 which are generally infiltrated by immune cells, the prognostic significance of which is controversial. 51, 54 Since the net outcome of the enrichment in tumor-infiltrating host cells cannot be easily predicted without defining their individual role in the antitumor defense, further clinicopathological studies are needed on human skin melanoma patients.
